| Brand Name: | Alafree |
| Generic: | Fexofenadine Hydrochloride |
| Weight: | 180 mg |
| Type: | Tablet |
| Therapeutic Class: | Non-sedating antihistamines |
| Manufacturer: | Apex Pharmaceuticals Ltd. |
| Price: | 11.20 |
| Last Updated: | 2020-11-20 18:15:00 |
Alafree Tablet contains Fexofenadine Hydrochloride. Alafree uses:
It is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis and chronic idiopathic urticaria.
Alafree Tablet contains Fexofenadine Hydrochloride 180 mg. Alafree doses:
Adults-
Children-
In case of decreased renal function, care should be taken in dose selection and it may be useful to monitor renal function.
Fexofenadine is generally well tolerated. The most commonly reported adverse events are headache, drowsiness, nausea, and dizziness. The incidence of these events observed with Fexofenadine hydrochloride was similar to that observed with placebo.
Alafree Tablet is an antihistamine with selective peripheral H1 receptor antagonist activity. It inhibits histamine release from peritoneal mast cells. No anticholinergic, α-1 adrenergic or β-adrenergic receptor blocking effects has been observed. No sedative or other central nervous system effect has been observed. It does not appear to cross the blood brain barrier.
Fexofenadine is rapidly absorbed after oral administration with peak plasma concentration being reached in 2-3 hours. Elimination half-life of about 14 hours has been reported although this may be prolonged in patients with renal impairment.
Studies in the elderly, patients with hepatic impairment and patients with cardiac disease exposed to Fexofenadine showed no statistically significant differences compared to healthy individuals. As with most new drugs there is only limited data in the elderly and renally or hepatically impaired patients. Fexofenadine hydrochloride should be administered with care in these special groups.
Co-administration of Alafree Tablet with either ketoconazole or erythromycin may cause increased plasma concentration of Fexofenadine. Antacid containing Aluminium and Magnesium may reduce the absorption of Fexofenadine. Fruit juices such as grapefruit, orange and apple may reduce the bioavailability of Fexofenadine.
Pregnancy Category B. There are no adequate and well controlled studies in pregnant women. Fexofenadine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Lactation: It is not known if Fexofenadine is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Fexofenadine is administered to a nursing woman.
Fexofenadine is contraindicated in patients with known hypersensitivity to Fexofenadine or any of the ingredients of this preparation.
Studies in special risk groups (elderly, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of Alafree Tablet in these patients.
In case of an overdose, standard measures to remove any unabsorbed drug should be employed. Symptomatic and supportive treatment is recommended. There has been no reported case of an acute overdose of Fexofenadine hydrochloride.
Store Fexofenadine at controlled room temperature 20-25 °C. Keep all medicines away from reach of children.
Alafree Tablet price in Bangladesh 11.20